| Ytd | 23.86% | |
| 1y | 712.17% |
| Open | 367.50 | Prev Close | 366.96 | Low | 361.37 | High | 372.00 | Mkt Cap | 10.18B |
| Vol | 134.84K | Avg Vol | 496.80K | EPS | -12.93 | P/E | -28.23 | Forward P/E | -39.31 |
| Beta | 2.78 | Short Ratio | 6.32 | Inst. Own | 118.68% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-07 | 50-d Avg | 306.31 | 200-d Avg | 290.45 | 1yr Est | 621.63 |
PRAX News
Prax is analyzed using a sum-of-parts valuation approach, focusing on its lead asset, Ulixa. Recent
Praxis Precision Medicines, Inc. (PRAX) Q2 2026 Earnings Call Transcript
Praxis Precision Medicines NASDAQ: PRAX said it is preparing for potential commercial launches of ul
US stocks mixed on Thurs. Dow Jones down 50 pts. Motorola Solutions Inc shares up 9.5% after reporti
BOSTON, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a fully i
BOSTON, July 30, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a fully i
Bank of New York Mellon Corp raised its holdings in Praxis Precision Medicines, Inc. (NASDAQ: PRAX)
Fifth Third Bancorp bought a new stake in Praxis Precision Medicines, Inc. (NASDAQ: PRAX) during the
Praxis Precision Medicines: Priced For Half Of What I Think It's Worth
Goldman Sachs analyst Kevin Strang initiates coverage on Praxis Precision Medicine (NASDAQ:PRAX)
Collaboration aims to quickly enable ulixacaltamide to be delivered via active transdermal route
BOSTON, July 02, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a fully i
FDA sets updated PDUFA date of December 27, 2026 BOSTON, June 29, 2026 (GLOBE NEWSWIRE) -- Praxis Pr
Top Wall Street analysts upgraded and downgraded several top companies, including Applied Materials,
Praxis Precision Medicines Inc. (NASDAQ:PRAX) said on Monday that the U.S. Food and Drug Administrat
The Breakthrough Therapy Designation (BTD) was granted based on the positive results from the EMBRAV
Praxis Precision Medicines, Inc. (PRAX) Presents at Goldman Sachs 47th Annual Global Healthcare Conf
Praxis Precision Medicines, Inc. is valued as a pure-play on ulixacaltamide's commercial launch in e
BOSTON, June 04, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a fully i
BOSTON, June 02, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a fully i
Wall Street analysts change ratings for top stocks: CRWD price target raised, FULC target lowered, H
Praxis Precision Medicines Inc. (NASDAQ:PRAX) on Monday reported results from its Phase 2/3 POWER1 s
Praxis Precision Medicines said on Monday its experimental epilepsy drug failed to meet the main go
POWER1 Study in highly refractory patients with focal onset seizures did not meet its primary succes
US stocks rise, Dow Jones gains 600+ pts. Apellis Pharma shares surge 136.4% after buyout by Biogen
On Friday, 93 stocks made new 52-week lows.
The collapse of SVB Financial Group (NASDAQ: SIVB) could have a ripple effect on the technology and
On Monday, 413 companies reached new 52-week lows.
On Friday morning, 446 companies hit new 52-week lows.
During Monday's trading, 1214 companies set new 52-week lows.
Monday's session saw 84 companies set new 52-week lows.
Wednesday's session saw 784 companies set new 52-week lows.
On Wednesday, 160 companies hit new 52-week lows.
On Tuesday, 242 companies hit new 52-week lows.
On Monday, 671 companies achieved new lows for the year.
Companies Reporting Before The Bell • Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to repo
Companies Reporting Before The Bell • R.R.Donnelley & Sons (NYSE:RRD) is likely to report qu
Gainers UTime Limited (NASDAQ: UTME) shares jumped 875% to close at $39.00 on Tuesday after the c
Gainers Clovis Oncology, Inc. (NASDAQ: CLVS) shares climbed 47.7% to close at $7.86 on Friday af